Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"610"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Multiple+sclerosis%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
/vufind/Search/Results?lookfor=%22Multiple+sclerosis%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
Search /vufind/Search2/Results?lookfor=%22Multiple+sclerosis%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
PubPharm (8.987)
1
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis : A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab : A Single-arm, Prospective, Multicentre, Open-label Study to Evaluate Ofatumumab Treatment Effectiveness and Patient-reported Outcomes (PRO) in Patients With Relapsing Multiple Sclerosis (RMS) Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension) : A 2-year Extension Study to Evaluate Long-term Effectiveness of Mavenclad® in Participants Who Have Completed Trial MS700568_0022 (MAGNIFY MS) (Magnify MS Extension)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis : A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study : FutureMS-2: Clinical, Laboratory, and Genomic Predictors of Disease Activity in People Diagnosed With Relapsing Onset Multiple Sclerosis: an Observational Cohort and Scottish Precision Medicine Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments : New perSEPtion. New Patient's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based RRMS Treatments.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis : Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer : A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden : INFORM - Interferon-Beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-Based Drug Utilisation Study in Finland and Sweden
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting : Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[899]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: 610
Medienart
8.987
Aufsätze
8.987
E-Artikel
8.987
E-Ressourcen
Zeitschriftentitel
6.000
WHO International Clinical Trials Registry Plat...
2.987
ClinicalTrials.gov
Thema
610
7.792
Study Type: Interventional
3.275
Recruitment Status: Not yet recruiting
2.987
Multiple Sclerosis
2.579
Sclerosis
2.487
Recruitment Status: Completed
2.015
Phase: Phase 3
1.205
Recruitment Status: Recruiting
1.118
Study Type: Observational
1.108
Recruitment Status: Authorised-recruitment may ...
1.038
Medical Condition: Multiple Sclerosis
858
Phase: Phase 2
578
Phase: Phase 4
533
Multiple Sclerosis, Relapsing-Remitting
211
Phase: Phase 1
206
Recruitment Status: Active, not recruiting
202
Recruitment Status: Terminated
195
Multiple Sclerosis, Chronic Progressive
167
Recruitment Status: Unknown status
154
Medical Condition: Multiple sclerosis. Multiple...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4.564
2020-
4.359
2010-2019
64
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.809
Englisch
116
Unbestimmt
38
Spanisch
16
Französisch
4
Deutsch
2
Dänisch
2
Niederländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...